Epizyme, Inc.
Substituted purine compounds
Last updated:
Abstract:
The present invention relates to substituted purine compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating disorders in which DOT1-mediated protein methylation plays a part, such as cancer, by administering these compounds and pharmaceutical compositions to subjects in need thereof.
Status:
Grant
Type:
Utility
Filling date:
23 Jun 2017
Issue date:
3 Sep 2019